Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on july 2, 2025, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 35,607 shares of common stock and 29,571 restricted stock units (“rsus”) to seventeen new employees under acadia's 2024 inducement plan. the compensation committee approved the awards as an inducement material to the new employees' em.
ACAD Ratings Summary
ACAD Quant Ranking